Endoprosthetic Replacement for Primary Malignant Tumors of the Proximal Femur

1999 ◽  
Vol 358 ◽  
pp. 8???14 ◽  
Author(s):  
Yavuz Kabukcuoglu ◽  
Robert J. Grimer ◽  
Roger M. Tillman ◽  
Simon R. Carter
2005 ◽  
Vol 15 (4) ◽  
pp. 218-222 ◽  
Author(s):  
M.A. Rosa ◽  
G. Maccauro ◽  
F. Muratori ◽  
M.G. Rodà

2011 ◽  
Vol 36 (4) ◽  
pp. 731-734 ◽  
Author(s):  
Benjamin John Floyd Dean ◽  
Jon J. Matthews ◽  
Andrew Price ◽  
David Stubbs ◽  
Duncan Whitwell ◽  
...  

2009 ◽  
Vol 91-B (1) ◽  
pp. 108-112 ◽  
Author(s):  
C. R. Chandrasekar ◽  
R. J. Grimer ◽  
S. R. Carter ◽  
R. M. Tillman ◽  
A. Abudu ◽  
...  

2020 ◽  
Vol 38 (15_suppl) ◽  
pp. e23500-e23500
Author(s):  
Ashish Gulia ◽  
Sri Harsha ◽  
Srinath Gupta ◽  
Ajay Puri

e23500 Background: Proximal femur endoprosthetic replacement(PFER) has become aprimary treatment option for aggressive benign and malignant tumors of proximal femur allowing early return to weight bearing and improvement in functional status. We present our experience in these cases with respect to oncological outcomes, functional outcomes and implant survival. Methods: All cases were retrieved from our prospectively maintained surgical database. 98 patients(35 males and 63 females) with a mean age of 29 years(10– 69 years)were operated between August 2006 and September 2017. Median followup was 49 months(1 - 160 months).The diagnosis included osteosarcoma(18), Ewing’s sarcoma(38), chondrosarcoma(32), and GCT(8) synovial sarcoma (2) .They were evaluated by Musculoskeletal Tumor Society score, recurrence free survival, patient survival, and implant survival. Results: Mean resection length is 18.5cm (8 – 35cm). 8 patients underwent revision surgery,7 for mechanical (3 for aseptic loosening, 4 for dislocations and for implant failures), 1 for non mechanicalcause (infection) and 2 patients underwent amputation for local recurrence. One patient had dislocation recently for whom revision is adbvised. At last follow-up, out of 98 cases 6 were lost to follow up, 32 patients had died(28 due to disease and 4 due to other causes) and 60 are alive. There were 3 only local recurrences(3 alive-1 external hemipelvectomy, 1 excision, 1 definitive chemo radiation), 9 had both local and distant recurrence (1 alive – hip disarticulation for local, definitive cheomoradiation for distant recurrence), and 26 had distant recurrences(6 alive - 3 pulmonary metastetectomy,1 nodal metastasis, 1 lung metastasis and 1 bone metastasis treated with definitive cheomoradiation) . The 5year OS, LRFS,DRFS were 68.3,85.7,61.5% respectively. The mean Musculoskeletal Tumor Society score was 26(22 – 28). The implant survival was 87.4% at 5 years. Conclusions: The use of a PFER in the treatment of primary tumours of bone is oncologically safe and gives consistent and predictable results with low rates of complication. We found that low cost indigenous prosthesis (one fourth the cost of imported prosthesis) fare equivalent to existing imported prosthesis. This can immensely helpful in offering limb salvage in resource constraint settings.


Sarcoma ◽  
2016 ◽  
Vol 2016 ◽  
pp. 1-9 ◽  
Author(s):  
Suhel Kotwal ◽  
Bryan Moon ◽  
Patrick Lin ◽  
Robert Satcher ◽  
Valerae Lewis

Humerus is a common site for malignant tumors. Advances in adjuvant therapies and reconstructive methods provide salvage of the upper limb with improved outcomes. Reports of limb salvage with total humeral replacement in extensive humeral tumors are sparse. We undertook a retrospective study of 20 patients who underwent total humeral endoprosthetic replacement as limb salvage following excision of extensile malignant tumor from 1990 to 2011. With an average followup of 42.9, functional and oncological outcomes were analyzed. Ten patients were still alive at the time of review. Mean estimated blood loss was 1131 mL and duration of surgery was 314 minutes. Deep infection was encountered in one patient requiring debridement while mechanical loosening of ulnar component was identified in one patient. Subluxation of prosthetic humeral head was noted in 3 patients. Mean active shoulder abduction was 12.5° and active flexion was 15°. Incompetence of abduction mechanism was the major determinant of poor active functional outcome. Mean elbow flexion was 103.5° with 30.5° flexion contracture in 10 patients with good and useful hand function. Average MSTS score was 71.5%. Total humeral replacement is a reliable treatment option in restoring mechanical stability and reasonable functional results without compromising patient survival, with low complication rate.


2018 ◽  
Vol 42 (11) ◽  
pp. 2691-2698
Author(s):  
Hongyuan Liu ◽  
Xiang Fang ◽  
Zeping Yu ◽  
Yun Lang ◽  
Yan Xiong ◽  
...  

2019 ◽  
Vol 34 (4) ◽  
pp. 700-703 ◽  
Author(s):  
Joshua D. Johnson ◽  
Kevin I. Perry ◽  
Brandon J. Yuan ◽  
Peter S. Rose ◽  
Matthew T. Houdek

2009 ◽  
Vol 17 (3) ◽  
pp. 280-283 ◽  
Author(s):  
Shah Alam Khan ◽  
Ashok Kumar ◽  
Prashanth Inna ◽  
Sameer Bakhshi ◽  
Shishir Rastogi

Author(s):  
Coonoor R Chandrasekar ◽  
Robert J Grimer ◽  
Simon R Carter ◽  
Roger M Tillman ◽  
Adesegun T Abudu

Sign in / Sign up

Export Citation Format

Share Document